{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:21:23Z","timestamp":1788351683434,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41433-026-04677-w","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:50:25Z","timestamp":1782453025000},"page":"1988-1992","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vision-related quality of life in non-neovascular age-related macular degeneration: a protocol for systematic review and meta-analysis"],"prefix":"10.1038","volume":"40","author":[{"given":"Guangwen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena","family":"Zeraatkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-605X","authenticated-orcid":false,"given":"Ryan E. K.","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ghadimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Pedro Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobha","family":"Sivaprasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2815-5031","authenticated-orcid":false,"given":"Enrico","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9441-4356","authenticated-orcid":false,"given":"Robyn H.","family":"Guymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Yin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles C.","family":"Wykoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9988-4146","authenticated-orcid":false,"given":"Varun","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"4677_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.mayocpiqo.2024.05.003","volume":"8","author":"N Boopathiraj","year":"2024","unstructured":"Boopathiraj N, Wagner IV, Dorairaj SK, Miller DD, Stewart MW. Recent updates on the diagnosis and management of age-related macular degeneration. Mayo Clin Proc Innov Qual Outcomes. 2024;8:364\u201374.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"4677_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2023.26074","volume":"331","author":"M Fleckenstein","year":"2024","unstructured":"Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U. Age-related macular degeneration: a review. JAMA. 2024;331:147\u201357.","journal-title":"JAMA"},{"key":"4677_CR3","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.2147\/OPTH.S469051","volume":"18","author":"P Yoganathan","year":"2024","unstructured":"Yoganathan P, Hurley B, Merkur A, Andrews C, Pereira JA, Moniz LS. Physical, psychosocial, and practical burden of patients receiving care for age-related macular degeneration in Canada: a mixed-methods qualitative study. Clin Ophthalmol. 2024;18:2951\u201367.","journal-title":"Clin Ophthalmol"},{"key":"4677_CR4","unstructured":"Deloitte Access Economics. The cost of vision loss and blindness in Canada. Canadian Council of the Blind. 2021. Available from: https:\/\/www.fightingblindness.ca\/wp-content\/uploads\/2021\/12\/Deloitte-Cost-of-vision-loss-and-blindness-in-Canada-report-May-2021.pdf."},{"key":"4677_CR5","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris 3rd","year":"2013","unstructured":"Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844\u201351.","journal-title":"Ophthalmology"},{"key":"4677_CR6","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.clinthera.2021.08.011","volume":"43","author":"NM Schultz","year":"2021","unstructured":"Schultz NM, Bhardwaj S, Barclay C, Gaspar L, Schwartz J. Global burden of dry age-related macular degeneration: a targeted literature review. Clin Ther. 2021;43:1792\u2013818.","journal-title":"Clin Ther"},{"key":"4677_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/1874467211104030196","volume":"4","author":"N Kuno","year":"2011","unstructured":"Kuno N, Fujii S. Dry age-related macular degeneration: recent progress of therapeutic approaches. Curr Mol Pharmacol. 2011;4:196\u2013232.","journal-title":"Curr Mol Pharmacol"},{"key":"4677_CR8","unstructured":"Day-Storms J. FDA Approval of SYFOVRE (Pegcetacoplan) and IZERVAY (Avacincaptad Pegol) Reshapes Management of GA 2023. Available from: https:\/\/www.ahdbonline.com\/issues\/2023\/september-2023-vol-16-payers-guide\/fda-approval-of-syfovre-pegcetacoplan-and-izervay-avacincaptad-pegol-reshapes-management-of-ga."},{"key":"4677_CR9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","volume":"119","author":"A randomized, placebo-controlled","year":"2001","unstructured":"A randomized, placebo-controlled. Clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417\u201336.","journal-title":"Arch Ophthalmol"},{"key":"4677_CR10","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.2013.4997","volume":"309","author":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration","year":"2013","unstructured":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration. The age-related eye disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309:2005\u201315.","journal-title":"JAMA"},{"key":"4677_CR11","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0161-6420(02)01060-6","volume":"109","author":"K Scilley","year":"2002","unstructured":"Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology. 2002;109:1235\u201342.","journal-title":"Ophthalmology"},{"key":"4677_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51769-7","volume":"9","author":"SG Pondorfer","year":"2019","unstructured":"Pondorfer SG, Terheyden JH, Heinemann M, Wintergerst MWM, Holz FG, Finger RP. Association of vision-related quality of life with visual function in age-related macular degeneration. Sci Rep. 2019;9:15326.","journal-title":"Sci Rep"},{"key":"4677_CR13","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2147\/OPTH.S45248","volume":"7","author":"M Yuzawa","year":"2013","unstructured":"Yuzawa M, Fujita K, Tanaka E, Wang EC. Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice. Clin Ophthalmol. 2013;7:1325\u201332.","journal-title":"Clin Ophthalmol"},{"key":"4677_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/bs.pbr.2025.03.007","volume":"292","author":"DJ Taylor","year":"2025","unstructured":"Taylor DJ, Enoch J, Jones L, Higgins B, Binns A, Crabb DP. An overview of quality of life and visual outcomes in AMD. Prog Brain Res. 2025;292:203\u201329.","journal-title":"Prog Brain Res"},{"key":"4677_CR15","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.2147\/OPTH.S115159","volume":"10","author":"T Nakano","year":"2016","unstructured":"Nakano T, Kawashima M, Hiratsuka Y, Tamura H, Ono K, Murakami A, et al. Assessment of quality of life in patients with visual impairments using a new visual function questionnaire: the VFQ-J11. Clin Ophthalmol. 2016;10:1939\u201344.","journal-title":"Clin Ophthalmol"},{"key":"4677_CR16","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050\u20138.","journal-title":"Arch Ophthalmol"},{"key":"4677_CR17","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/bjo.84.9.1035","volume":"84","author":"JS Wolffsohn","year":"2000","unstructured":"Wolffsohn JS, Cochrane AL, Watt NA. Implementation methods for vision-related quality of life questionnaires. Br J Ophthalmol. 2000;84:1035\u201340.","journal-title":"Br J Ophthalmol"},{"key":"4677_CR18","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ics.2005.05.043","volume":"1282","author":"F Fylan","year":"2005","unstructured":"Fylan F, Morrison-Fokken A, Grunfeld EA. Focus-QoL: Measuring quality of life in low vision. Int Congr Ser. 2005;1282:549\u201353.","journal-title":"Int Congr Ser"},{"key":"4677_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11136-016-1395-2","volume":"26","author":"EK Fenwick","year":"2017","unstructured":"Fenwick EK, Man RE, Rees G, Keeffe J, Wong TY, Lamoureux EL. Reducing respondent burden: validation of the Brief Impact of Vision Impairment questionnaire. Qual Life Res. 2017;26:479\u201388.","journal-title":"Qual Life Res"},{"key":"4677_CR20","doi-asserted-by":"crossref","unstructured":"Terheyden JH, Fink DJ, Pondorfer SG, Holz FG, Finger RP. Instrumental activities of daily living tools in very-low vision: ready for use in trials? Pharmaceutics. 2022;14:2435.","DOI":"10.3390\/pharmaceutics14112435"},{"key":"4677_CR21","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/acr.20524","volume":"63","author":"ST Angeles-Han","year":"2011","unstructured":"Angeles-Han ST, Griffin KW, Harrison MJ, Lehman TJ, Leong T, Robb RR, et al. Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res. 2011;63:1254\u201361.","journal-title":"Arthritis Care Res"},{"key":"4677_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00061198-200306000-00006","volume":"12","author":"GC Rossi","year":"2003","unstructured":"Rossi GC, Milano G, Tinelli C. The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliability. J Glaucoma. 2003;12:213\u201320.","journal-title":"J Glaucoma"},{"key":"4677_CR23","first-page":"A4290","volume":"58","author":"MS S\u00f8rensen","year":"2011","unstructured":"S\u00f8rensen MS, Andersen S, Henningsen GO, Larsen CT, S\u00f8rensen TL. Danish version of visual function questionnaire-25 and its use in age-related macular degeneration. Dan Med Bull. 2011;58:A4290.","journal-title":"Dan Med Bull"},{"key":"4677_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-019-1203-0","volume":"17","author":"E Jelin","year":"2019","unstructured":"Jelin E, Wisl\u00f8ff T, Moe MC, Heiberg T. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ 25) in a Norwegian population of patients with neovascular age-related macular degeneration compared to a control population. Health Qual Life Outcomes. 2019;17:140.","journal-title":"Health Qual Life Outcomes"},{"key":"4677_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2018.03.006","volume":"190","author":"S Sivaprasad","year":"2018","unstructured":"Sivaprasad S, Tschosik E, Kapre A, Varma R, Bressler NM, Kimel M, et al. Reliability and construct validity of the NEI VFQ-25 in a subset of patients with geographic atrophy from the phase 2 Mahalo study. Am J Ophthalmol. 2018;190:1\u20138.","journal-title":"Am J Ophthalmol"},{"key":"4677_CR26","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1167\/iovs.10-5645","volume":"52","author":"P Orr","year":"2011","unstructured":"Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, et al. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Investig Ophthalmol Vis Sci. 2011;52:3354\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4677_CR27","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1167\/iovs.08-3225","volume":"50","author":"IJ Su\u00f1er","year":"2009","unstructured":"Su\u00f1er IJ, Kokame GT, Yu E, Ward J, Dolan C, Bressler NM. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials. Investig Ophthalmol Vis Sci. 2009;50:3629\u201335.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4677_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12955-015-0330-5","volume":"13","author":"B Kovac","year":"2015","unstructured":"Kovac B, Vukosavljevic M, Djokic Kovac J, Resan M, Trajkovic G, Jankovic J, et al. Validation and cross-cultural adaptation of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) in Serbian patients. Health Qual Life Outcomes. 2015;13:142.","journal-title":"Health Qual Life Outcomes"},{"key":"4677_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/09286586.2022.2093919","volume":"30","author":"CM V\u00e9lez","year":"2023","unstructured":"V\u00e9lez CM, Ram\u00edrez PB, Oviedo-C\u00e1ceres MDP, Lugo Agudelo LH, Posada AM, Hern\u00e1ndez-Padilla ML, et al. Psychometric properties of scales for assessing the vision-related quality of life of people with low vision: a systematic review. Ophthalmic Epidemiol. 2023;30:239\u201348.","journal-title":"Ophthalmic Epidemiol"},{"key":"4677_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.10.1.5","volume":"10","author":"SG Pondorfer","year":"2021","unstructured":"Pondorfer SG, Terheyden JH, Overhoff H, Stasch-Bouws J, Holz FG, Finger RP. Development of the vision impairment in the low luminance questionnaire. Transl Vis Sci Technol. 2021;10:5.","journal-title":"Transl Vis Sci Technol"},{"key":"4677_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/tvst.11.4.21","volume":"11","author":"JH Terheyden","year":"2022","unstructured":"Terheyden JH, Mekschrat L, Ost RAD, Bildik G, Berger M, Wintergerst MWM, et al. Interviewer administration corresponds to self-administration of the Vision Impairment in Low Luminance (VILL) Questionnaire. Transl Vis Sci Technol. 2022;11:21.","journal-title":"Transl Vis Sci Technol"},{"key":"4677_CR32","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/bjophthalmol-2021-320848","volume":"107","author":"JH Terheyden","year":"2023","unstructured":"Terheyden JH, Pondorfer SG, Behning C, Berger M, Carlton J, Rowen D, et al. Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration\u2014a MACUSTAR study report. Br J Ophthalmol. 2023;107:1144\u201350.","journal-title":"Br J Ophthalmol"},{"key":"4677_CR33","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s11136-021-02989-w","volume":"31","author":"EK Fenwick","year":"2022","unstructured":"Fenwick EK, Lee EPX, Man REK, Ho KC, Najjar RP, Milea D, et al. Identifying the content for an item bank and computerized adaptive testing system to measure the impact of age-related macular degeneration on health-related quality of life. Qual Life Res. 2022;31:1237\u201346.","journal-title":"Qual Life Res"},{"key":"4677_CR34","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","volume":"116","author":"CM Mangione","year":"1998","unstructured":"Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol. 1998;116:1496\u2013504.","journal-title":"Arch Ophthalmol"},{"key":"4677_CR35","doi-asserted-by":"publisher","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. JBI; 2020. Available from: https:\/\/synthesismanual.jbi.global. https:\/\/doi.org\/10.46658\/JBIMES-20-08.","DOI":"10.46658\/JBIMES-20-08"},{"key":"4677_CR36","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1080\/08820538.2016.1181192","volume":"32","author":"I Chatziralli","year":"2017","unstructured":"Chatziralli I, Mitropoulos P, Parikakis E, Niakas D, Labiris G. Risk factors for poor quality of life among patients with age-related macular degeneration. Semin Ophthalmol. 2017;32:772\u201380.","journal-title":"Semin Ophthalmol"},{"key":"4677_CR37","doi-asserted-by":"publisher","first-page":"e3971","DOI":"10.1136\/bmj.e3971","volume":"344","author":"P Sedgwick","year":"2012","unstructured":"Sedgwick P. Meta-analyses: tests of heterogeneity. Br Med J. 2012;344:e3971.","journal-title":"Br Med J"},{"key":"4677_CR38","doi-asserted-by":"crossref","unstructured":"Rothstein HR, Sutton AJ, Borenstein M. Publication bias in meta-analysis. Publication Bias in Meta-Analysis 2005.","DOI":"10.1002\/0470870168"},{"key":"4677_CR39","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"4677_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jclinepi.2023.05.010","volume":"159","author":"HJ Sch\u00fcnemann","year":"2023","unstructured":"Sch\u00fcnemann HJ, Brennan S, Akl EA, Hultcrantz M, Alonso-Coello P, Xia J, et al. The development methods of official GRADE articles and requirements for claiming the use of GRADE \u2013 a statement by the GRADE guidance group. J Clin Epidemiol. 2023;159:79\u201384.","journal-title":"J Clin Epidemiol"}],"updated-by":[{"DOI":"10.1038\/s41433-026-04787-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000}}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04677-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04677-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04677-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:58:43Z","timestamp":1788350323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04677-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":40,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4677"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04677-w","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article the authorship has been updated. Dr. Jo\u00e3o Pedro Lobo Lima and Dr. Maryam Ghadimi were unintentionally omitted from the published author list. In this article the authors Maryam Ghadimi and Jo\u00e3o Pedro Lima have been added to this article. The authorship now is as follows: Please find below the complete authorship and affiliation list. The two authors who should be added to the published version are highlighted in bold. Guangwen Sun<sup>1<\/sup>, Dena Zeraatkar<sup>2, 3, 4<\/sup>, Ryan E K Man<sup>5, 6<\/sup>, Maryam Ghadimi<sup>2,7<\/sup>, Jo\u00e3o Pedro Lima<sup>2,7<\/sup>, Sobha Sivaprasad<sup>8<\/sup>, Enrico Borrelli<sup>9,10<\/sup>, David H. Steel<sup>11, 12<\/sup>, Robyn H. Guymer<sup>13, 14<\/sup>, Tien Yin Wong<sup>5,15<\/sup>, Charles C. Wykoff<sup>16<\/sup>, Jinhui Ma<sup>4<\/sup>, Varun Chaudhary<sup>2, 4, 7<\/sup>* <sup>1<\/sup>Faculty of Health Sciences, School of Nutrition Sciences, University of Ottawa, Ottawa, Ontario, Canada <sup>2<\/sup>Division of Ophthalmology, Department of Surgery, McMaster University, Hamilton, ON, Canada <sup>3<\/sup>Department of Anesthesia, McMaster University, Hamilton, ON, Canada <sup>4<\/sup>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada <sup>5<\/sup>Singapore Eye Research Institute, Singapore National Eye Centre, Singapore <sup>6<\/sup>Ophthalmology and Visual Science Academic Clinical Programme, Duke-NUS Medical School, Singapore <sup>7<\/sup>Thomas Kevill Advanced Vitreoretinal Imaging (AVI) Lab, St Joseph\u2019s Healthcare, Hamilton, ON, Canada <sup>8<\/sup>NIHR Biomedical Research Centre at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK <sup>9<\/sup>Vita-Salute San Raffaele University, Milan, Italy <sup>10<\/sup>San Raffaele Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Milan, Italy <sup>11<\/sup>Bioscience Institute, Newcastle University, Newcastle Upon Tyne, UK <sup>12<\/sup>Sunderland Eye Infirmary, Queen Alexandra Road, Sunderland, UK <sup>13<\/sup>Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia <sup>14<\/sup>Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Australia <sup>15<\/sup>Beijing Visual Science and Translational Eye Research Institute, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China. <sup>16<\/sup>Retina Consultants of Texas, Houston, Texas, USA The original article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41433-026-04787-5","URL":"https:\/\/doi.org\/10.1038\/s41433-026-04787-5","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Enrico Borrelli and Varun Chaudhary are members of the Eye editorial board. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}